731 related articles for article (PubMed ID: 17302204)
1. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Choudhry S; Ghosh S
Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
[TBL] [Abstract][Full Text] [Related]
4. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
5. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
6. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
9. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Batioğlu F; Ozmert E; Parmak N; Celik S
Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P
Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293
[TBL] [Abstract][Full Text] [Related]
12. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
13. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Minezaki T; Noma H
Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.
Cellini M; Pazzaglia A; Zamparini E; Leonetti P; Campos EC
BMC Ophthalmol; 2008 Mar; 8():5. PubMed ID: 18366650
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.
Takata C; Messias A; Folgosa MS; Lucena LR; Lucena DR; Scott IU; Jorge R
Retina; 2010 Apr; 30(4):562-9. PubMed ID: 20182403
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
Paccola L; Costa RA; Folgosa MS; Barbosa JC; Scott IU; Jorge R
Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
[TBL] [Abstract][Full Text] [Related]
18. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
